- Akari will host an analyst and investor symposium on Saturday, Dec 3 - NEW YORK and LONDON, November 3rd, 2016 Akari Therapeutics (NASDAQ: AKTX), an …
Akari Therapeutics Appoints New Members to its Board of Directors
NEW YORK and LONDON, October 14th, 2016 Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today the …
[Read more...] about Akari Therapeutics Appoints New Members to its Board of Directors
Akari Therapeutics Joins aHUS Alliance in Recognizing International aHUS Awareness Day
The 2nd annual aHUS Awareness Day will be marked on 24 September 2016. Updates from aHUS patient organizations and supporters from around the world will be …
Akari Therapeutics to Present at Upcoming Investor Conferences on September 27 and 28 in New York City
NEW YORK and LONDON, September 16th, 2016 Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced that Dr. …
Akari Therapeutics Announces Receipt of Orphan Drug Designation for Coversin from the U.S. FDA for Treatment of Paroxysmal Nocturnal Hemoglobinuria
NEW YORK and LONDON, September 12th, 2016 Akari Therapeutics (NASDAQ: AKTX), an emerging growth, development-stage biopharmaceutical company, announced today …
